To view in Chinese (coming soon)

Lilly Asian Ventures

Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management teams and innovative technology and/or business models. Our initial focus will be primarily on opportunities in China, although we will consider investment opportunities elsewhere in east and south Asia.

Global Resources and Industry Expertise

Eli Lilly and Company is a leading, innovation-driven corporation committed to developing best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly employs approximately 40,000 employees and markets products in 145 countries. In 2006, Eli Lilly recorded sales of $15.7 Billion USD, and invested 20% of sales in R&D. Lilly Ventures, Lilly's initial venture fund established in 2001, has invested in over two dozen companies. Lilly Asian Ventures was established in 2007 with a geographic focus on the emerging life science businesses of east and south Asia, particularly India and China.

Lilly Asian Ventures is an active and "value added" investor bringing critical strategic capabilities, from both across the globe and in Asia, that facilitate the success of portfolio companies.

Access to industry knowledge and contacts
Lilly Asian Ventures has access to the collective knowledge and contact base of Lilly's world-class scientists, experienced clinical investigators and respected sales and marketing professionals.

Product insights
Our affiliation with Eli Lilly and Company also greatly enhances our ability to evaluate new technologies and therapies from a customer or prospective partner perspective.

Strategic relationships
Through our collaborations with industry experts, the venture capital industry and investment banks, we tap into a global network of contacts to assist portfolio companies with various aspects of growing their business.

Active investors with an operational focus
Our experienced team takes board seats and works closely with management teams to help build the business creating long-term value for the company and its investors.

Investment Focus

Lilly Asian Ventures is looking for promising life science companies with strong management teams and innovative technology and/or business models. We will invest in companies with a global orientation as well as companies that can be leaders in the Chinese market. We invest in companies at various stages of development from start-up to commercialization in lifescience sectors such as biotechnology and pharmaceuticals, medical devices and diagnostics (especially where linked with a therapeutic), and healthcare services.